Evidence map›Paper›PMID 20719834›Full record

ArticleThe Journal of clinical endocrinology and metabolism2010

High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study.

Na Zhu, James S Pankow, Christie M Ballantyne, David Couper, Ron C Hoogeveen, Mark Pereira, Bruce B Duncan, Maria Inês Schmidt

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 2 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 2 syntheses or guidelines pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. NRH, a potent NADMetabolism: clinical and experimental · 2025
    Article
  10. The Interconnected Complexity of Diabetes and Depression.Diabetes spectrum : a publication of the American Diabetes Association · 2025
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Na ZhuDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Suite 300, Minneapolis, Minnesota 55454, USA. zhuxx210@umn.edu
James S Pankow
Christie M Ballantyne
David Couper
Ron C Hoogeveen
Mark Pereira
Bruce B Duncan
Maria Inês Schmidt
University of Minnesota · USBaylor College of Medicine · USUniversidade Federal do Rio Grande do Sul · BRUniversity of North Carolina at Chapel Hill · US

Funding

INFLAMMATORY PRECURSORS OF TYPE 2 DIABETESR01DK056918 · NIDDK · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI PANKOW, JAMES S · 2000 to 2008
$2.6M
COMMUNITY AND COHORT SURVEILLANCE PROGRAMS-N01HC55015N01HC055015 · HC · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI CHAMBLESS, LLOYD E · 1985 to 2006
$1.1M
COMMUNITY AND COHORT SURVEILLANCE PROGRAMN01HC055016 · HC · BAYLOR COLLEGE OF MEDICINE · PI BALLANTYNE, CHRISTIE M · 1985 to 2000
$785k
FIELD CENTER FOR CCSPN01HC055019 · HC · UNIVERSITY OF MINNESOTA TWIN CITIES · PI FOLSOM, AARON R · 1985 to 2000
$748k
FIELD CENTERN01HC055021 · HC · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI JONES, DANIEL W · 1985 to 2000
$617k
CCSP-FIELD CENTERN01HC055020 · HC · JOHNS HOPKINS UNIVERSITY · PI NIETO, F JAVIER · 1985 to 2000
$334k
CENTRAL HEMOSTATIS LABORATORY FOR CCSPN01HC055022 · HC · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI WU, KENNETH K · 1985 to 2000
$264k
CCSP--FIELD CENTER AND ULTRASOUND READING CENTERN01HC055018 · HC · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI HEISS, GERARDO · 1985 to 2000
$104k
SKELETAL MUSCLE ENERGY CONVERTOR FOR CARDIAC ASSISTANCER41HL055018 · NHLBI · THORATEC LABORATORIES CORPORATION · PI FARRAR, DAVID J · 1995 to 1995
–
RAPID IMMUNODETECTION OF CARDIAC PROTEINS IN WHOLE BLOODR41HL055019 · NHLBI · SELECTIVE TECHNOLOGIES, INC. · PI MARTIN, GLENN B · 1995 to 1995
–
SKELETAL MUSCLE ENGERGY CONVERTOR FOR CARDIAC ASSISTANCER42HL055018 · NHLBI · THORATEC LABORATORIES CORPORATION · PI FARRAR, DAVID J · 1998 to 1999
–
NHLBI NIH HHS N01 HC055015NHLBI NIH HHS N01 HC055016NHLBI NIH HHS N01 HC055018NHLBI NIH HHS N01 HC055019NHLBI NIH HHS N01 HC055020NHLBI NIH HHS N01 HC055021NHLBI NIH HHS N01 HC055022NHLBI NIH HHS N01-HC-55015NHLBI NIH HHS N01-HC-55016NHLBI NIH HHS N01-HC-55018NHLBI NIH HHS N01-HC-55019NHLBI NIH HHS N01-HC-55020NHLBI NIH HHS N01-HC-55021NHLBI NIH HHS N01-HC-55022NIDDK NIH HHS R01 DK056918NIDDK NIH HHS R01-DK56918
6 · The paper itself

Abstract

contextAdiponectin, synthesized by adipocytes, has been shown to be a predictor of type 2 diabetes. Adiponectin circulates in plasma as three oligomeric isoforms. High-molecular-weight (HMW) adiponectin is thought to be the most biologically active form of adiponectin in terms of glucose homeostasis.

objectiveOur objective was to investigate whether HMW adiponectin is more strongly associated with incident diabetes than is total adiponectin.

designA nested case-cohort study was conducted in a population-based cohort of 9740 middle-aged, initially healthy, white and African-American participants of the Atherosclerosis Risk in Communities (ARIC) study followed for up to 9 yr. Plasma total and HMW adiponectin were measured by ELISA in 550 incident diabetes cases and 540 noncases.

resultsOverall hazard ratios (95% confidence intervals) for developing diabetes for those in the fourth (vs. the first) quartile of total adiponectin, HMW adiponectin, and the ratio of HMW to total were 0.40 (0.25-0.64), 0.38 (0.23-0.63), and 0.65 (0.42-0.99), respectively, after adjustment for age, sex, ethnicity, study center, parental history of diabetes, hypertension, body mass index, and waist-to-hip ratio and 0.52 (0.32-0.85), 0.51 (0.31-0.86), and 0.77 (0.50-1.20), respectively, after additional adjustment for inflammation score (a score composed of six inflammation markers) and fasting insulin. When further adjusting for baseline fasting glucose, the graded associations were attenuated substantially and lost their gradation.

conclusionsIn this community-based sample of U.S. adults, higher total and HMW adiponectin concentrations were similarly associated with a lower incidence of diabetes over 9 yr of follow-up.

Indexed as

AdiponectinBlack or African AmericanBlood GlucoseCase-Control StudiesDiabetes Mellitus, Type 2Enzyme-Linked Immunosorbent AssayFemaleFollow-Up StudiesHumansIncidenceMaleMiddle AgedRiskWaist-Hip RatioWhite PeopleAdiponectinBlood Glucose

Identifiers

PMID20719834
PMCPMC2968724
OpenAlexW2061579222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.